Singapore markets closed
  • Straits Times Index

    3,201.86
    -3.28 (-0.10%)
     
  • S&P 500

    4,544.90
    -4.88 (-0.11%)
     
  • Dow

    35,677.02
    +73.92 (+0.21%)
     
  • Nasdaq

    15,090.20
    -125.50 (-0.82%)
     
  • BTC-USD

    62,557.43
    +1,623.95 (+2.67%)
     
  • CMC Crypto 200

    1,453.34
    -49.70 (-3.31%)
     
  • FTSE 100

    7,246.33
    +41.78 (+0.58%)
     
  • Gold

    1,800.60
    +4.30 (+0.24%)
     
  • Crude Oil

    84.42
    +0.66 (+0.79%)
     
  • 10-Yr Bond

    1.6550
    0.0000 (0.00%)
     
  • Nikkei

    28,600.41
    -204.44 (-0.71%)
     
  • Hang Seng

    26,132.03
    +5.10 (+0.02%)
     
  • FTSE Bursa Malaysia

    1,587.94
    -0.14 (-0.01%)
     
  • Jakarta Composite Index

    6,625.70
    -18.04 (-0.27%)
     
  • PSE Index

    7,211.54
    -78.07 (-1.07%)
     

Global Near Infrared Imaging Market to Reach $1.3 Billion by 2027

·25-min read

Abstract: - Global Near Infrared Imaging Market to Reach $1. 3 Billion by 2027. - Amid the COVID-19 crisis, the global market for Near Infrared Imaging estimated at US$533.

New York, Sept. 24, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Near Infrared Imaging Industry" - https://www.reportlinker.com/p06032317/?utm_source=GNW
5 Million in the year 2020, is projected to reach a revised size of US$1.3 Billion by 2027, growing at aCAGR of 14% over the period 2020-2027. Devices, one of the segments analyzed in the report, is projected to record 13.1% CAGR and reach US$845.3 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Reagents segment is readjusted to a revised 15.7% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $157.6 Million, While China is Forecast to Grow at 13.5% CAGR
- The Near Infrared Imaging market in the U.S. is estimated at US$157.6 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$232.9 Million by the year 2027 trailing a CAGR of 13.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.4% and 12% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 10.2% CAGR.

- Select Competitors (Total 42 Featured) -

  • Artinis Medical Systems

  • Bruker

  • Carl Zeiss Meditec

  • Fluoptics

  • Hamamatsu Photonics K.K.

  • Infrared Thermal Imaging and Near IR Illumination Products

  • Innopharma Labs

  • IRCameras LLC

  • Karl Storz SE & Co. KG

  • Leica Microsystems

  • LI-COR, Inc.

  • Malvern Panalytical Ltd

  • Medtronic

  • Miltenyi Biotec

  • Olympus Corporation

  • PerkinElmer Inc.

  • Quest Medical Imaging BV

  • Shimadzu Corporation

  • Stryker

  • Thermo Fisher Scientific Inc




Read the full report: https://www.reportlinker.com/p06032317/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Near Infrared
Imaging by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 2: World Historic Review for Near Infrared Imaging by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 3: World 15-Year Perspective for Near Infrared Imaging by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Devices by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 5: World Historic Review for Devices by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Devices by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

Table 7: World Current & Future Analysis for Reagents by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 8: World Historic Review for Reagents by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Reagents by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

Table 10: World Current & Future Analysis for Research
Laboratories by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 11: World Historic Review for Research Laboratories by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 12: World 15-Year Perspective for Research Laboratories
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Pharma & Biotech
Companies by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 14: World Historic Review for Pharma & Biotech Companies
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 15: World 15-Year Perspective for Pharma & Biotech
Companies by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Hospitals &
Clinics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 17: World Historic Review for Hospitals & Clinics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 18: World 15-Year Perspective for Hospitals & Clinics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Cancer Surgeries
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 20: World Historic Review for Cancer Surgeries by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 21: World 15-Year Perspective for Cancer Surgeries by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Plastic /
Reconstructive Surgeries by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 23: World Historic Review for Plastic / Reconstructive
Surgeries by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 24: World 15-Year Perspective for Plastic /
Reconstructive Surgeries by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

Table 25: World Current & Future Analysis for Gastrointestinal
Surgeries by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 26: World Historic Review for Gastrointestinal Surgeries
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 27: World 15-Year Perspective for Gastrointestinal
Surgeries by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2020 & 2027

Table 28: World Current & Future Analysis for Cardiovascular
Surgeries by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 29: World Historic Review for Cardiovascular Surgeries by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 30: World 15-Year Perspective for Cardiovascular
Surgeries by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2020 & 2027

Table 31: World Current & Future Analysis for Preclinical
Imaging by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 32: World Historic Review for Preclinical Imaging by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 33: World 15-Year Perspective for Preclinical Imaging by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 34: World Current & Future Analysis for Other
Applications by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 35: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 36: World 15-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 37: USA Current & Future Analysis for Near Infrared
Imaging by Product - Devices and Reagents - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 38: USA Historic Review for Near Infrared Imaging by
Product - Devices and Reagents Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 39: USA 15-Year Perspective for Near Infrared Imaging by
Product - Percentage Breakdown of Value Sales for Devices and
Reagents for the Years 2012, 2020 & 2027

Table 40: USA Current & Future Analysis for Near Infrared
Imaging by End-Use - Research Laboratories, Pharma & Biotech
Companies and Hospitals & Clinics - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 41: USA Historic Review for Near Infrared Imaging by
End-Use - Research Laboratories, Pharma & Biotech Companies and
Hospitals & Clinics Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 42: USA 15-Year Perspective for Near Infrared Imaging by
End-Use - Percentage Breakdown of Value Sales for Research
Laboratories, Pharma & Biotech Companies and Hospitals &
Clinics for the Years 2012, 2020 & 2027

Table 43: USA Current & Future Analysis for Near Infrared
Imaging by Application - Cancer Surgeries, Plastic /
Reconstructive Surgeries, Gastrointestinal Surgeries,
Cardiovascular Surgeries, Preclinical Imaging and Other
Applications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 44: USA Historic Review for Near Infrared Imaging by
Application - Cancer Surgeries, Plastic / Reconstructive
Surgeries, Gastrointestinal Surgeries, Cardiovascular
Surgeries, Preclinical Imaging and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 45: USA 15-Year Perspective for Near Infrared Imaging by
Application - Percentage Breakdown of Value Sales for Cancer
Surgeries, Plastic / Reconstructive Surgeries, Gastrointestinal
Surgeries, Cardiovascular Surgeries, Preclinical Imaging and
Other Applications for the Years 2012, 2020 & 2027

CANADA
Table 46: Canada Current & Future Analysis for Near Infrared
Imaging by Product - Devices and Reagents - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 47: Canada Historic Review for Near Infrared Imaging by
Product - Devices and Reagents Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 48: Canada 15-Year Perspective for Near Infrared Imaging
by Product - Percentage Breakdown of Value Sales for Devices
and Reagents for the Years 2012, 2020 & 2027

Table 49: Canada Current & Future Analysis for Near Infrared
Imaging by End-Use - Research Laboratories, Pharma & Biotech
Companies and Hospitals & Clinics - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 50: Canada Historic Review for Near Infrared Imaging by
End-Use - Research Laboratories, Pharma & Biotech Companies and
Hospitals & Clinics Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 51: Canada 15-Year Perspective for Near Infrared Imaging
by End-Use - Percentage Breakdown of Value Sales for Research
Laboratories, Pharma & Biotech Companies and Hospitals &
Clinics for the Years 2012, 2020 & 2027

Table 52: Canada Current & Future Analysis for Near Infrared
Imaging by Application - Cancer Surgeries, Plastic /
Reconstructive Surgeries, Gastrointestinal Surgeries,
Cardiovascular Surgeries, Preclinical Imaging and Other
Applications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 53: Canada Historic Review for Near Infrared Imaging by
Application - Cancer Surgeries, Plastic / Reconstructive
Surgeries, Gastrointestinal Surgeries, Cardiovascular
Surgeries, Preclinical Imaging and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 54: Canada 15-Year Perspective for Near Infrared Imaging
by Application - Percentage Breakdown of Value Sales for Cancer
Surgeries, Plastic / Reconstructive Surgeries, Gastrointestinal
Surgeries, Cardiovascular Surgeries, Preclinical Imaging and
Other Applications for the Years 2012, 2020 & 2027

JAPAN
Table 55: Japan Current & Future Analysis for Near Infrared
Imaging by Product - Devices and Reagents - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 56: Japan Historic Review for Near Infrared Imaging by
Product - Devices and Reagents Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 57: Japan 15-Year Perspective for Near Infrared Imaging
by Product - Percentage Breakdown of Value Sales for Devices
and Reagents for the Years 2012, 2020 & 2027

Table 58: Japan Current & Future Analysis for Near Infrared
Imaging by End-Use - Research Laboratories, Pharma & Biotech
Companies and Hospitals & Clinics - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 59: Japan Historic Review for Near Infrared Imaging by
End-Use - Research Laboratories, Pharma & Biotech Companies and
Hospitals & Clinics Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 60: Japan 15-Year Perspective for Near Infrared Imaging
by End-Use - Percentage Breakdown of Value Sales for Research
Laboratories, Pharma & Biotech Companies and Hospitals &
Clinics for the Years 2012, 2020 & 2027

Table 61: Japan Current & Future Analysis for Near Infrared
Imaging by Application - Cancer Surgeries, Plastic /
Reconstructive Surgeries, Gastrointestinal Surgeries,
Cardiovascular Surgeries, Preclinical Imaging and Other
Applications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 62: Japan Historic Review for Near Infrared Imaging by
Application - Cancer Surgeries, Plastic / Reconstructive
Surgeries, Gastrointestinal Surgeries, Cardiovascular
Surgeries, Preclinical Imaging and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 63: Japan 15-Year Perspective for Near Infrared Imaging
by Application - Percentage Breakdown of Value Sales for Cancer
Surgeries, Plastic / Reconstructive Surgeries, Gastrointestinal
Surgeries, Cardiovascular Surgeries, Preclinical Imaging and
Other Applications for the Years 2012, 2020 & 2027

CHINA
Table 64: China Current & Future Analysis for Near Infrared
Imaging by Product - Devices and Reagents - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 65: China Historic Review for Near Infrared Imaging by
Product - Devices and Reagents Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 66: China 15-Year Perspective for Near Infrared Imaging
by Product - Percentage Breakdown of Value Sales for Devices
and Reagents for the Years 2012, 2020 & 2027

Table 67: China Current & Future Analysis for Near Infrared
Imaging by End-Use - Research Laboratories, Pharma & Biotech
Companies and Hospitals & Clinics - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 68: China Historic Review for Near Infrared Imaging by
End-Use - Research Laboratories, Pharma & Biotech Companies and
Hospitals & Clinics Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 69: China 15-Year Perspective for Near Infrared Imaging
by End-Use - Percentage Breakdown of Value Sales for Research
Laboratories, Pharma & Biotech Companies and Hospitals &
Clinics for the Years 2012, 2020 & 2027

Table 70: China Current & Future Analysis for Near Infrared
Imaging by Application - Cancer Surgeries, Plastic /
Reconstructive Surgeries, Gastrointestinal Surgeries,
Cardiovascular Surgeries, Preclinical Imaging and Other
Applications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 71: China Historic Review for Near Infrared Imaging by
Application - Cancer Surgeries, Plastic / Reconstructive
Surgeries, Gastrointestinal Surgeries, Cardiovascular
Surgeries, Preclinical Imaging and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 72: China 15-Year Perspective for Near Infrared Imaging
by Application - Percentage Breakdown of Value Sales for Cancer
Surgeries, Plastic / Reconstructive Surgeries, Gastrointestinal
Surgeries, Cardiovascular Surgeries, Preclinical Imaging and
Other Applications for the Years 2012, 2020 & 2027

EUROPE
Table 73: Europe Current & Future Analysis for Near Infrared
Imaging by Geographic Region - France, Germany, Italy, UK and
Rest of Europe Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 74: Europe Historic Review for Near Infrared Imaging by
Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 75: Europe 15-Year Perspective for Near Infrared Imaging
by Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2012, 2020 & 2027

Table 76: Europe Current & Future Analysis for Near Infrared
Imaging by Product - Devices and Reagents - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 77: Europe Historic Review for Near Infrared Imaging by
Product - Devices and Reagents Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 78: Europe 15-Year Perspective for Near Infrared Imaging
by Product - Percentage Breakdown of Value Sales for Devices
and Reagents for the Years 2012, 2020 & 2027

Table 79: Europe Current & Future Analysis for Near Infrared
Imaging by End-Use - Research Laboratories, Pharma & Biotech
Companies and Hospitals & Clinics - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 80: Europe Historic Review for Near Infrared Imaging by
End-Use - Research Laboratories, Pharma & Biotech Companies and
Hospitals & Clinics Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 81: Europe 15-Year Perspective for Near Infrared Imaging
by End-Use - Percentage Breakdown of Value Sales for Research
Laboratories, Pharma & Biotech Companies and Hospitals &
Clinics for the Years 2012, 2020 & 2027

Table 82: Europe Current & Future Analysis for Near Infrared
Imaging by Application - Cancer Surgeries, Plastic /
Reconstructive Surgeries, Gastrointestinal Surgeries,
Cardiovascular Surgeries, Preclinical Imaging and Other
Applications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 83: Europe Historic Review for Near Infrared Imaging by
Application - Cancer Surgeries, Plastic / Reconstructive
Surgeries, Gastrointestinal Surgeries, Cardiovascular
Surgeries, Preclinical Imaging and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 84: Europe 15-Year Perspective for Near Infrared Imaging
by Application - Percentage Breakdown of Value Sales for Cancer
Surgeries, Plastic / Reconstructive Surgeries, Gastrointestinal
Surgeries, Cardiovascular Surgeries, Preclinical Imaging and
Other Applications for the Years 2012, 2020 & 2027

FRANCE
Table 85: France Current & Future Analysis for Near Infrared
Imaging by Product - Devices and Reagents - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 86: France Historic Review for Near Infrared Imaging by
Product - Devices and Reagents Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 87: France 15-Year Perspective for Near Infrared Imaging
by Product - Percentage Breakdown of Value Sales for Devices
and Reagents for the Years 2012, 2020 & 2027

Table 88: France Current & Future Analysis for Near Infrared
Imaging by End-Use - Research Laboratories, Pharma & Biotech
Companies and Hospitals & Clinics - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 89: France Historic Review for Near Infrared Imaging by
End-Use - Research Laboratories, Pharma & Biotech Companies and
Hospitals & Clinics Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 90: France 15-Year Perspective for Near Infrared Imaging
by End-Use - Percentage Breakdown of Value Sales for Research
Laboratories, Pharma & Biotech Companies and Hospitals &
Clinics for the Years 2012, 2020 & 2027

Table 91: France Current & Future Analysis for Near Infrared
Imaging by Application - Cancer Surgeries, Plastic /
Reconstructive Surgeries, Gastrointestinal Surgeries,
Cardiovascular Surgeries, Preclinical Imaging and Other
Applications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 92: France Historic Review for Near Infrared Imaging by
Application - Cancer Surgeries, Plastic / Reconstructive
Surgeries, Gastrointestinal Surgeries, Cardiovascular
Surgeries, Preclinical Imaging and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 93: France 15-Year Perspective for Near Infrared Imaging
by Application - Percentage Breakdown of Value Sales for Cancer
Surgeries, Plastic / Reconstructive Surgeries, Gastrointestinal
Surgeries, Cardiovascular Surgeries, Preclinical Imaging and
Other Applications for the Years 2012, 2020 & 2027

GERMANY
Table 94: Germany Current & Future Analysis for Near Infrared
Imaging by Product - Devices and Reagents - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 95: Germany Historic Review for Near Infrared Imaging by
Product - Devices and Reagents Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 96: Germany 15-Year Perspective for Near Infrared Imaging
by Product - Percentage Breakdown of Value Sales for Devices
and Reagents for the Years 2012, 2020 & 2027

Table 97: Germany Current & Future Analysis for Near Infrared
Imaging by End-Use - Research Laboratories, Pharma & Biotech
Companies and Hospitals & Clinics - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 98: Germany Historic Review for Near Infrared Imaging by
End-Use - Research Laboratories, Pharma & Biotech Companies and
Hospitals & Clinics Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 99: Germany 15-Year Perspective for Near Infrared Imaging
by End-Use - Percentage Breakdown of Value Sales for Research
Laboratories, Pharma & Biotech Companies and Hospitals &
Clinics for the Years 2012, 2020 & 2027

Table 100: Germany Current & Future Analysis for Near Infrared
Imaging by Application - Cancer Surgeries, Plastic /
Reconstructive Surgeries, Gastrointestinal Surgeries,
Cardiovascular Surgeries, Preclinical Imaging and Other
Applications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 101: Germany Historic Review for Near Infrared Imaging by
Application - Cancer Surgeries, Plastic / Reconstructive
Surgeries, Gastrointestinal Surgeries, Cardiovascular
Surgeries, Preclinical Imaging and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 102: Germany 15-Year Perspective for Near Infrared
Imaging by Application - Percentage Breakdown of Value Sales
for Cancer Surgeries, Plastic / Reconstructive Surgeries,
Gastrointestinal Surgeries, Cardiovascular Surgeries,
Preclinical Imaging and Other Applications for the Years 2012,
2020 & 2027

ITALY
Table 103: Italy Current & Future Analysis for Near Infrared
Imaging by Product - Devices and Reagents - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 104: Italy Historic Review for Near Infrared Imaging by
Product - Devices and Reagents Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 105: Italy 15-Year Perspective for Near Infrared Imaging
by Product - Percentage Breakdown of Value Sales for Devices
and Reagents for the Years 2012, 2020 & 2027

Table 106: Italy Current & Future Analysis for Near Infrared
Imaging by End-Use - Research Laboratories, Pharma & Biotech
Companies and Hospitals & Clinics - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 107: Italy Historic Review for Near Infrared Imaging by
End-Use - Research Laboratories, Pharma & Biotech Companies and
Hospitals & Clinics Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 108: Italy 15-Year Perspective for Near Infrared Imaging
by End-Use - Percentage Breakdown of Value Sales for Research
Laboratories, Pharma & Biotech Companies and Hospitals &
Clinics for the Years 2012, 2020 & 2027

Table 109: Italy Current & Future Analysis for Near Infrared
Imaging by Application - Cancer Surgeries, Plastic /
Reconstructive Surgeries, Gastrointestinal Surgeries,
Cardiovascular Surgeries, Preclinical Imaging and Other
Applications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 110: Italy Historic Review for Near Infrared Imaging by
Application - Cancer Surgeries, Plastic / Reconstructive
Surgeries, Gastrointestinal Surgeries, Cardiovascular
Surgeries, Preclinical Imaging and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 111: Italy 15-Year Perspective for Near Infrared Imaging
by Application - Percentage Breakdown of Value Sales for Cancer
Surgeries, Plastic / Reconstructive Surgeries, Gastrointestinal
Surgeries, Cardiovascular Surgeries, Preclinical Imaging and
Other Applications for the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 112: UK Current & Future Analysis for Near Infrared
Imaging by Product - Devices and Reagents - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 113: UK Historic Review for Near Infrared Imaging by
Product - Devices and Reagents Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 114: UK 15-Year Perspective for Near Infrared Imaging by
Product - Percentage Breakdown of Value Sales for Devices and
Reagents for the Years 2012, 2020 & 2027

Table 115: UK Current & Future Analysis for Near Infrared
Imaging by End-Use - Research Laboratories, Pharma & Biotech
Companies and Hospitals & Clinics - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 116: UK Historic Review for Near Infrared Imaging by
End-Use - Research Laboratories, Pharma & Biotech Companies and
Hospitals & Clinics Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 117: UK 15-Year Perspective for Near Infrared Imaging by
End-Use - Percentage Breakdown of Value Sales for Research
Laboratories, Pharma & Biotech Companies and Hospitals &
Clinics for the Years 2012, 2020 & 2027

Table 118: UK Current & Future Analysis for Near Infrared
Imaging by Application - Cancer Surgeries, Plastic /
Reconstructive Surgeries, Gastrointestinal Surgeries,
Cardiovascular Surgeries, Preclinical Imaging and Other
Applications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 119: UK Historic Review for Near Infrared Imaging by
Application - Cancer Surgeries, Plastic / Reconstructive
Surgeries, Gastrointestinal Surgeries, Cardiovascular
Surgeries, Preclinical Imaging and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 120: UK 15-Year Perspective for Near Infrared Imaging by
Application - Percentage Breakdown of Value Sales for Cancer
Surgeries, Plastic / Reconstructive Surgeries, Gastrointestinal
Surgeries, Cardiovascular Surgeries, Preclinical Imaging and
Other Applications for the Years 2012, 2020 & 2027

REST OF EUROPE
Table 121: Rest of Europe Current & Future Analysis for Near
Infrared Imaging by Product - Devices and Reagents -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 122: Rest of Europe Historic Review for Near Infrared
Imaging by Product - Devices and Reagents Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 123: Rest of Europe 15-Year Perspective for Near Infrared
Imaging by Product - Percentage Breakdown of Value Sales for
Devices and Reagents for the Years 2012, 2020 & 2027

Table 124: Rest of Europe Current & Future Analysis for Near
Infrared Imaging by End-Use - Research Laboratories, Pharma &
Biotech Companies and Hospitals & Clinics - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 125: Rest of Europe Historic Review for Near Infrared
Imaging by End-Use - Research Laboratories, Pharma & Biotech
Companies and Hospitals & Clinics Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 126: Rest of Europe 15-Year Perspective for Near Infrared
Imaging by End-Use - Percentage Breakdown of Value Sales for
Research Laboratories, Pharma & Biotech Companies and Hospitals &
Clinics for the Years 2012, 2020 & 2027

Table 127: Rest of Europe Current & Future Analysis for Near
Infrared Imaging by Application - Cancer Surgeries, Plastic /
Reconstructive Surgeries, Gastrointestinal Surgeries,

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06032317/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting